Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ascendiant Capital Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $8.5

Author: Benzinga Newsdesk | June 24, 2024 05:41am
Ascendiant Capital analyst Edward Woo initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $8.5.

Posted In: COCH